April 13, 2021 07:05 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India surpasses Brazil with 1.35 crore overall cases of Covid-19 | Kerala's vaccine stocks will last only three more days: CM Pinarayi Vijayan writes to Centre | Haryana govt imposes night curfew amid steep rise in Covid cases | Bengal polls: ECI bans Mamata Banerjee from campaigning for 24 hours starting 8 pm tonight | Sushil Chandra to take over as new Chief Election Commissioner from tomorrow

Pfizer cancels Covid-19 vaccine delivery to Canada for next week

Canada/IBNS: Pfizer-BioNTech cancelled its delivery of Covid 19 doses to Canada for the next week, said Maj.-Gen. Dany Fortin, the military commander leading vaccine logistics for the federal government.

Health Canada, FDA closely watching for any adverse reactions of Pfizer vaccine

Canada/IBNS: Health Canada and US Food and Drug Administration (FDA) are being cautious for any unexpected side effects of COVID-19 vaccines after a health worker in Alaska (US), with no history of allergies, had a severe anaphylactic reaction to the vaccine, and after Britain reported two similar cases last week, media reports said.  

Canada: Alberta plans to send COVID-19 teams to hard-hit areas in Edmonton, Calgary

Alberta/IBNS: Alberta Premier Jason Kenney said that its government is planning to send COVID-19 teams into the 11 hardest-hit neighbourhoods in Edmonton and Calgary to offer masks, hand sanitizer and to provide free hotel rooms to allow people in those areas to self-isolate if necessary.

Toronto to receive Ontario's 1st doses of Pfizer COVID-19 vaccine today

Ontario/IBNS: Toronto will receive the first doses of the Pfizer-BioNTech COVID-19 vaccine on Monday, said retired general Rick Hillier, the head of the province's vaccine distribution task force.

Health Canada approves use of Pfizer-BioNTech COVID-19 vaccine

Canada/IBNS: Health Canada has announced its approval of the use of Pfizer-BioNTech's COVID-19 vaccine in Canada for people over the age of 16 after a two-month review of the company's clinical trial data was completed by the scientists.